Rationale:The role of pulmonary function before stem cell transplant as a potential risk factor for the development of early post-transplant respiratory failure and mortality is controversial. Methods: We conducted a retrospective analysis of the pretransplant pulmonary function of 2,852 patients who received their transplant between 1990 and 2001. Measurements: Pretransplant FEV 1 , FVC, total lung capacity (TLC), diffusing capacity of carbon monoxide (DL CO ), and the alveolar-arterial oxygen tension difference P(A-a)O 2 were measured and assessed for association with development of early respiratory failure and mortality in Cox proportional hazard logistic models. lung function before transplant increases the risk for posttransplant pulmonary complications (2-6) and mortality (3,7,8). These findings were not, however, confirmed in the largest study conducted by Crawford and Fisher (9), in 1992, which did not find spirometric or lung volume measurements to be associated with mortality. In addition, the majority of these analyses disagreed on which pretransplant lung function parameter was the strongest predictor of post-transplant pulmonary complications and mortality and they were limited by relatively small cohorts consisting of both autologous and allogeneic HCT patients (1,(4)(5)(6)8). Given the conflicting conclusions of previous studies and the significant changes in HCT care over the last decade, we conducted a 12-year retrospective cohort study to assess whether compromised pretransplant pulmonary function is associated with an increased risk for developing early respiratory failure and post-transplant mortality among adult allogeneic HCT patients. Some of the results of these studies have been previously reported in the form of an abstract (10).